ACRS
Aclaris Therapeutics, Inc.Data: 2026-10-21
Quick Stats
Oct 21, 202655.2
AI Score
HOLD0.71
Volume Ratio
Nov 05, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
ACRS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
ACRS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
ACRS Options - Sort by Max open Interest (near term)
21st October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Daily Out of Money Options - Sort by Max open Interest (near term)
21st October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Daily In the Money Options - Sort by Max open Interest (near term)
21st October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Most Active Options by Volume(near term)
21st October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRS Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ACRS Stock Summary
Last updated Oct 21, 2026
ACRS is currently trading at $3.81, positioned below its 200-day moving average of $4.49, suggesting bearish momentum. The stock has a 52-week range of $2.03 to $6.5999.
Technical Analysis: The 50-day moving average stands at $5.19, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.411, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.0, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ACRS at 55.2/100 with a HOLD recommendation.
ACRS (Aclaris Therapeutics, Inc.) Indicators
Last updated Oct 21, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.411 |
| CMF (20) | -0.0 |
| ROC (10) | 12.059 |
| ADX (14) | 44.409 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.492 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -53.056 |
| MFI (14) | 38.173 |
ACRS Candlestick Patterns
No validated candlestick patterns fired for ACRS in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Aclaris Therapeutics, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.
ACRS Moving Averages Analysis
ACRS (Aclaris Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 21, 2026
| Days | MA |
|---|---|
| 10 | 3.59 |
| 20 | 4.13 |
| 30 | 4.58 |
| 50 | 5.19 |
| 100 | 5.18 |
| 200 | 4.49 |
ACRS Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 554.9 million |
| Earnings/Share ($) | -0.58 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.6464 |
| EPS Estimate Next Year ($) | -0.7846 |
| WallStreet Target Price ($) | 10.18 |
| Most Recent Quarter |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.